COVID-19
Data from the initial COVID-19 vaccine shipments and wastage across the United States has been made available, revealing insights into the logistical challenges associated with the vaccine supply chain. The study, conducted in collaboration with NC State University and BuzzFeed News, analyzed data from the national Centers for Disease Control
COVID-19
Research at University Medical Center Mannheim has documented a case of acute myocarditis following mRNA COVID-19 vaccination. The study highlights the utility of cardiac magnetic resonance imaging (CMR) in the diagnosis and follow-up of patients with myocarditis. The patient, a 23-year-old male, presented with chest pain after receiving the second
COVID-19
A recent study has found that solid organ transplant (SOT) recipients are at high risk for complications from COVID-19, with vaccine breakthrough infections being common. Researchers at the University Health Network in Toronto, Canada, investigated the effectiveness of three doses of mRNA vaccine and early monoclonal antibody therapy in reducing
COVID-19
Research conducted at the Baylor University College of Medicine has found a possible link between the Pfizer-BioNTech mRNA vaccine and COVID-19 infection and the development of thrombotic thrombocytopenic purpura (TTP) in adolescents. The study describes three cases of TTP in adolescents, two of whom developed the condition after receiving the
COVID-19
The global iron & steel scrap recycling market is experiencing significant growth, with an estimated size of $380.74 billion in 2021, $411.26 billion in 2022, and a projected growth to $610.71 billion by 2027, driven by the increasing demand for environmentally friendly processes, government regulations, and policies
COVID-19
The global regenerative medicine market is expected to witness significant growth, driven by increasing demand for advanced medical treatments and rising investments in research and development. According to a report by Research and Markets, the market size was estimated at USD 16.69 billion in 2021 and is projected to
COVID-19
A recent study published in Human Vaccines & Immunotherapeutics has revealed two cases of adolescents who developed acute tubulointerstitial nephritis after receiving the second dose of the BNT162b2 COVID-19 mRNA vaccine. This is the first reported case of acute tubulointerstitial nephritis in pediatric patients linked to SARS-CoV-2 vaccination. The study
COVID-19
A study published in Clinical Immunology Communications has described a rare case of an individual with pre-existing autoimmunity who developed severe autoimmune symptoms after receiving the Pfizer-BioNTech COVID-19 vaccine. The patient, a 64-year-old Caucasian female, experienced progressively worsening fingertip necrosis and other symptoms associated with systemic lupus erythematosus (SLE) and
COVID-19
As the bat-flu outbreak is now two years past, the companies that helped re-open the locked-down economy have faced significant changes in fortune. While some of the world's largest vaccine makers failed to produce jabs that gained approval, six other drug-makers managed to succeed. Companies like Pfizer, AstraZeneca,
COVID-19
Research has shown that weakened immune systems of blood cancer patients can improve after receiving a third COVID-19 vaccination. Patients with lymphoma have been found to have defects in their immunity system, limiting its response to vaccination. However, a recent study discovered improvements in antibody and T-Cell responses after a
COVID-19
The global regenerative medicine market size was estimated at $16.69 billion in 2021 and is projected to grow at a CAGR of 20.03% to reach $49.94 billion by 2027. The market is expected to be driven by increasing adoption of stem cell technologies, gene therapies, and tissue
COVID-19
The global regenerative medicine market size was estimated at USD 16.69 billion in 2021 and is expected to reach USD 20.01 billion in 2022. This growth is driven by increasing adoption of stem cell technologies, gene therapies, and tissue engineering, as well as technological advancements in regenerative medicine
